Milestone Pharmaceuticals is trading at $1.14 (+5.11%), with the move apparently mainly supported by healthcare-sector momentum and XLV up 1.55% pre-market.
- No fresh company-specific announcement was identified for August 20, 2026; the latest earnings update was released August 12.
- Recent news showed expanding CARDAMYST insurance coverage and ongoing trial progress, but does not clearly explain this morning’s move.